Hsbc Holdings PLC Novo Nordisk A S Transaction History

Hsbc Holdings PLC

  • $168 Billion
  • Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Hsbc Holdings PLC holds 130,789 shares of NVO stock, worth $13.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
130,789
Previous 54,804 138.65%
Holding current value
$13.7 Million
Previous $7.82 Million 99.09%
% of portfolio
0.01%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$119.07 - $145.42 $9.05 Million - $11 Million
75,985 Added 138.65%
130,789 $15.6 Million
Q2 2024

Aug 12, 2024
BUY
$122.71 - $146.91 $1.09 Million - $1.31 Million
8,922 Added 19.45%
54,804 $7.82 Million
Q1 2024

May 15, 2024
SELL
$102.11 - $135.92 $2.11 Million - $2.81 Million
-20,638 Reduced 31.03%
45,882 $5.89 Million
Q4 2023

Feb 12, 2024
BUY
$87.78 - $105.45 $310,214 - $372,660
3,534 Added 5.61%
66,520 $6.88 Million
Q3 2023

Nov 13, 2023
SELL
$90.94 - $199.54 $25.1 Million - $55.2 Million
-276,447 Reduced 81.44%
62,986 $5.73 Million
Q2 2023

Aug 11, 2023
BUY
$155.98 - $172.65 $48.5 Million - $53.7 Million
311,080 Added 1097.17%
339,433 $54.9 Million
Q1 2023

May 15, 2023
BUY
$132.34 - $159.14 $40,760 - $49,015
308 Added 1.1%
28,353 $4.51 Million
Q4 2022

Feb 14, 2023
SELL
$102.55 - $135.33 $1.04 Million - $1.37 Million
-10,155 Reduced 26.58%
28,045 $3.8 Million
Q3 2022

Nov 14, 2022
SELL
$95.28 - $116.93 $290,318 - $356,285
-3,047 Reduced 7.39%
38,200 $3.81 Million
Q2 2022

Aug 11, 2022
BUY
$103.24 - $121.81 $214,739 - $253,364
2,080 Added 5.31%
41,247 $4.6 Million
Q1 2022

May 16, 2022
BUY
$93.1 - $112.54 $73,176 - $88,456
786 Added 2.05%
39,167 $4.35 Million
Q4 2021

Feb 11, 2022
BUY
$95.88 - $117.08 $407,010 - $497,004
4,245 Added 12.44%
38,381 $4.3 Million
Q3 2021

Nov 12, 2021
SELL
$84.42 - $106.62 $32,923 - $41,581
-390 Reduced 1.13%
34,136 $3.28 Million
Q2 2021

Aug 13, 2021
SELL
$67.66 - $84.76 $105,143 - $131,717
-1,554 Reduced 4.31%
34,526 $2.89 Million
Q1 2021

May 14, 2021
BUY
$67.06 - $75.82 $1.97 Million - $2.23 Million
29,447 Added 443.95%
36,080 $2.43 Million
Q4 2020

Feb 12, 2021
SELL
$63.89 - $73.8 $160,172 - $185,016
-2,507 Reduced 27.43%
6,633 $463,000
Q3 2020

Nov 12, 2020
BUY
$63.69 - $70.22 $110,502 - $121,831
1,735 Added 23.43%
9,140 $634,000
Q2 2020

Aug 14, 2020
SELL
$58.54 - $67.94 $127,617 - $148,109
-2,180 Reduced 22.74%
7,405 $485,000
Q1 2020

May 15, 2020
SELL
$49.46 - $64.78 $61,627 - $80,715
-1,246 Reduced 11.5%
9,585 $577,000
Q4 2019

Feb 14, 2020
SELL
$49.86 - $58.26 $59,084 - $69,038
-1,185 Reduced 9.86%
10,831 $626,000
Q3 2019

Nov 14, 2019
SELL
$47.54 - $53.43 $52,579 - $59,093
-1,106 Reduced 8.43%
12,016 $621,000
Q2 2019

Aug 13, 2019
SELL
$46.79 - $52.47 $78,420 - $87,939
-1,676 Reduced 11.33%
13,122 $670,000
Q1 2019

May 15, 2019
BUY
$46.36 - $52.63 $447,374 - $507,879
9,650 Added 187.45%
14,798 $774,000
Q4 2018

Feb 13, 2019
BUY
$41.54 - $47.25 $26,460 - $30,098
637 Added 14.12%
5,148 $237,000
Q3 2018

Nov 13, 2018
SELL
$46.76 - $51.24 $156,879 - $171,910
-3,355 Reduced 42.65%
4,511 $212,000
Q2 2018

Aug 10, 2018
SELL
$44.29 - $50.42 $177,071 - $201,579
-3,998 Reduced 33.7%
7,866 $362,000
Q1 2018

May 11, 2018
BUY
$48.49 - $58.14 $254,427 - $305,060
5,247 Added 79.3%
11,864 $584,000
Q4 2017

Feb 14, 2018
SELL
$47.53 - $53.73 $152,000 - $171,828
-3,198 Reduced 32.58%
6,617 $355,000
Q3 2017

Nov 14, 2017
BUY
$41.15 - $49.22 $46,334 - $55,421
1,126 Added 12.96%
9,815 $473,000
Q2 2017

Aug 14, 2017
BUY
N/A
8,689
8,689 $372,000

Others Institutions Holding NVO

# of Institutions
1,954
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email